Latest From Biotech Now

2012 BIO Investor Forum: Discovery Track Snapshot

cablecar

BIO’s 11th Annual BIO Investor Forum is just around the corner – it will be held October 9-10, 2012 at the Palace Hotel in San Francisco, CA. The forum, or BIF as we call it around here, is an international investor event which explores trends and opportunities in life sciences. Broadly speaking, the focus is on venture-stage growth and emerging public companies. BIO’s Alan Eisenberg said it best earlier this week: “The aim of the Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

#BIF2012 Company Snapshot: ContraFect Corporation

ContraFect

The BIO Investor Forum is fast approaching! Below you’ll find our first Company Snapshot of one of the event’s presenting companies, ContraFect Corporation. Continue reading to learn more about ContraFect’s product, their strategies, and what you can expect from their company in the coming months. Company Snapshot What is your company’s lead product or technology? ContraFect is a private company developing biotherapeutics for resistant, life threatening infections. Our lead compound, CF-301, is a bacteriophage lysin, Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO India Hosts Biopharmaceutical Regulatory and Policy Roundtable

bio-india-btn

During last week’s BIO India International Conference, BIO, in partnership with the Association of Biotech-Led Enterprises (ABLE) and the Confederation of Indian Industries (CII) held a roundtable to discuss ways that U.S. and Indian industry can work together to facilitate the development of new biotechnology products and commercialization. Participants in the roundtable represented U.S. and Indian industry, academia, and government and shared their views on critical issues important to the development of the Indian biotechnology Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

New Report Shows Strength of Massachusetts’ Biotech Industry

arrow

If you read this blog, there’s a good chance you already know that Massachusetts is one of the biggest biotech hubs in the world. The Commonwealth’s successes in biotech economic development can be attributed to a number of things. Perhaps foremost, its world-class universities, such as MIT and Harvard, continue to churn out the innovation that keeps venture groups interested. Meanwhile, established biotechs and Big Pharma continue to focus more and more R&D work in Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

The Importance of Encouraging Adult Vaccination This Fall

William Schaffner

As National Immunization Awareness Month ends and flu season approaches, many adults around the country are making plans to get their annual influenza vaccine.  In recent years, awareness of the need for influenza vaccination among adults has increased, however, immunization rates among US adults to prevent other vaccine-preventable diseases (VPDs) is still well below current public health goals.  While getting an influenza vaccine is a great first step, we still have a long way to Read More >

Health  |  Leave a comment  |  Email This Post